Literature DB >> 8800836

Modelling HIV vaccination.

A R McLean1, S M Blower.   

Abstract

Relatively recently, mathematical models have been applied to issues r elated to HIV vaccination. Significant progress has been made towards understanding how rather ineffective vaccines will perform in trials and in the community, but some areas still need research.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8800836     DOI： 10.1016/s0966-842x(00)89010-1

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  15 in total

1.  Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.

Authors:  Nimalan Arinaminpathy; Oliver Ratmann; Katia Koelle; Suzanne L Epstein; Graeme E Price; Cecile Viboud; Mark A Miller; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

2.  The evolutionary epidemiology of vaccination.

Authors:  Sylvain Gandon; Troy Day
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

3.  Demand forecasting for preventive AIDS vaccines: economic and policy dimensions.

Authors:  Robert Hecht; Gian Gandhi
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.

Authors:  S M Blower; K Koelle; D E Kirschner; J Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  A model of bovine tuberculosis control in domesticated cattle herds.

Authors:  R R Kao; M G Roberts; T J Ryan
Journal:  Proc Biol Sci       Date:  1997-07-22       Impact factor: 5.349

6.  Potential population health outcomes and expenditures of HIV vaccination strategies in the United States.

Authors:  Elisa F Long; Margaret L Brandeau; Douglas K Owens
Journal:  Vaccine       Date:  2009-07-08       Impact factor: 3.641

7.  Quantifying child mortality reductions related to measles vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Marc Lipsitch; Ajay Mahal; Alan M Zaslavsky; Joshua A Salomon
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

8.  Seven challenges in modeling vaccine preventable diseases.

Authors:  C J E Metcalf; V Andreasen; O N Bjørnstad; K Eames; W J Edmunds; S Funk; T D Hollingsworth; J Lessler; C Viboud; B T Grenfell
Journal:  Epidemics       Date:  2014-08-27       Impact factor: 4.396

9.  Lessons from previous predictions of HIV/AIDS in the United States and Japan: epidemiologic models and policy formulation.

Authors:  Hiroshi Nishiura
Journal:  Epidemiol Perspect Innov       Date:  2007-06-13

10.  Potential future impact of a partially effective HIV vaccine in a southern African setting.

Authors:  Andrew N Phillips; Valentina Cambiano; Fumiyo Nakagawa; Deborah Ford; Jens D Lundgren; Edith Roset-Bahmanyar; François Roman; Thierry Van Effelterre
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.